School of Medicine, The Chinese University of Hong Kong, Shenzhen, Guangdong, China.

Prof. Liu is the founder of the Biomedical Engineering Programme at the School of Medicine, The Chinese University of Hong Kong, Shenzhen. She is the Director of CUHKSZ-Boyalife Joint Laboratory of Regenerative Medicine Engineering. Her research interests include biomedical engineering, biosensors, nanobiotechnology, in vitro diagnostics, wearable devices, and in vivo continuous monitoring. Her career has been marked by a dynamic interplay between academia and industry. Her Integrated Devices and Intelligent Diagnostics (ID²) Laboratory focuses on developing biosensing tools and intelligent nanoparticles for the early diagnosis and prevention of chronic diseases. Her team has pioneered various CRISPR/Cas biosensors capable of quantifying inflammation from point-of-care testing and real-time in vivo monitoring. Her global impact is reflected in her being listed among the top 0.05% scholar in biosensors by ScholarGPS. She holds prestigious fellowships from the RSC, IET, and IPEM, alongside the CChem chartered status. As a dedicated advocate for women in STEM, she received the 2026 IPEM Gold Award in Academia and the Georgina Sweet Award for Women in Quantitative Biomedical Science in 2020. She currently serves as an Associate Editor for ACS Sensors and has been named a Distinguished Lecturer of the IEEE Sensors Council (2026–2028). Beyond academia, she has extensive industry experience in biomedical device development, including roles at AstraZeneca and as R&D Manager, China, at AgaMatrix Inc. She is a co-founder of Bio-Sens Tech in Sydney.